- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ABT-384
Total 5096 results
-
AmgenCompletedMigraineUnited States, Belgium, Netherlands
-
Boehringer IngelheimCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
MedImmune LLCPRA Health Sciences; Cambridge Antibody TechnologyTerminatedAsthmaNetherlands, United Kingdom, Australia, Germany, Poland
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AbbVie (prior sponsor, Abbott)Completed
-
AbbVieActive, not recruitingAtopic DermatitisUnited States, Norway, Puerto Rico
-
Deciphera Pharmaceuticals LLCRecruitingMelanoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Pancreatic Ductal Adenocarcinoma | BRAF Gene Mutation | RAS Mutation | NF1 Mutation | RAF Mutation | CRAF Gene MutationUnited States
-
Lantern Pharma Inc.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
AbbVieRecruitingHuman Immuno-deficiency Virus (HIV) DiseaseUnited States, Puerto Rico, Japan, Spain, Germany, Canada, Belgium, France, Poland, South Africa, Italy
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
AVEO Pharmaceuticals, Inc.Completed
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
AbbottCompletedHypogonadal MalesUnited States
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSmall Cell Lung Carcinoma | Small Cell Lung CancerUnited States, Canada, United Kingdom
-
TakedaCompletedHealthy VolunteersUnited States
-
AbbVieCompletedLymphoblastic Lymphoma | Acute Lymphoblastic Leukemia (ALL)United States, Australia
-
AbbVieCompletedHepatitis C Virus InfectionUnited States, Australia, Canada, China, Germany, Korea, Republic of, New Zealand, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
Agios Pharmaceuticals, Inc.Completed
-
Maastricht University Medical CenterCompletedSarcopeniaNetherlands
-
National Institute of Diabetes and Digestive and...Completed
-
Southern Europe New Drug OrganizationClinical Trial Unit Ente Ospedaliero CantonaleCompletedAdvanced Head and Neck Squamous Cancer
-
Yale UniversityCompleted
-
AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, Australia, Israel, Poland, Ukraine
-
AbbottGenentech, Inc.CompletedHealthy Female SubjectsUnited States
-
King Faisal UniversityMansoura UniversityCompletedLung Diseases | Esophageal DiseasesEgypt
-
National Cancer Institute (NCI)TerminatedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Recurrent Lung Small Cell Carcinoma | Stage IIIA Lung Small Cell Carcinoma AJCC v7 | Stage IIIB Lung Small Cell Carcinoma AJCC v7 | Stage IV Lung Small Cell... and other conditionsUnited States
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
AutotelicbioRecruitingDiabetes Mellitus, Type 2 | Essential HypertensionKorea, Republic of
-
AbbVieCompletedChronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 1a
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Groupe Francophone des MyelodysplasiesAbbVieRecruitingChronic Myeloid LeukemiaFrance
-
AbbVieActive, not recruitingSpinal Cord Injury (SCI)United States, Australia, Canada, Israel, Japan, Korea, Republic of, Spain
-
Frontier Biotechnologies Inc.Unknown